FERRING
Ferring today announced the recipients of the 2016-2017 Ferring Innovation Grants program, an annual initiative of the Ferring Research Institute (FRI) which provides grants of up to $100,000 for early stage research.
The program focuses on novel extracellular drug targets addressable with peptides or proteins within Ferring’s core therapeutic areas: reproductive health, gastroenterology, urology, and endocrinology.
The 2016-2017 awardees and their research subjects are:
Stuart Brierley - Flinders University, Australia
Venom-derived
NaV1.1 inhibitors as novel candidates for treating chronic visceral pain
associated with IBS
James Deane - Hudson Institute of Medical Research, Australia
Investigating
the requirement for Notch and Hedgehog signalling in the endometrial
stem/progenitor populations that cause endometriosis
Laurent Derré – Centre Hospitalier Universitaire Vaudois, Switzerland
Understanding
Siglec-related immunity in bladder cancer
Marie van Dijk - University of Amsterdam, Netherlands
ELABELA as
a potential biomarker and therapeutic for pre-eclampsia
Renjie Jin - Vanderbilt University Medical Center, USA
Sensitizing
castration-resistant prostate cancer to anti-androgens by targeting
gastrin-releasing peptide receptor
Florenta Kullmann - University of Pittsburgh, USA
Artemin: a
novel target for treatment of interstitial cystitis/bladder pain syndrome
Mireille Lahoud - Monash University, Australia
The development
of Clec12A-ligands as a therapeutic approach to regulate
gastrointestinal inflammation
Padma Murthi - Monash University, Australia
Investigating the
role of novel peptide receptor as an effective target to improve
placental function in preeclampsia
Markus Muttenthaler - The University of Queensland, Australia
Mapping
the location and function of oxytocin and vasopressin receptors
throughout the gut
Rodrigo Pacheco – Fundación Ciencia & Vida and Universidad Andres Bello,
Santiago, Chile
Targeting heteromers formed by G-protein coupled
receptors involved in the gut-homing of T-cells in inflammatory bowel
diseases
Aritro Sen – The University of Rochester, USA
Regulation of AMH
expression by GDF9+BMP15 and FSH during follicular development as a
novel therapeutic option
“We look forward to the outcomes of the research being carried out by our grant awardees,” said Keith James, President of FRI and Senior Vice President, Research and Development. “Ferring is committed to stimulating basic research, with the ultimate aim of developing innovative products that improve the lives of patients.”
Applications for the 2017-2018 Ferring Innovation Grants programme will open in spring/summer 2017. For more information on this year’s program, visit www.ferring-research.com/ferring-grants .
ENDS
About Ferring Research Institute Inc
Located in San Diego,
California Ferring Research Institute Inc. (FRI) is the global peptide
therapeutics research center for Ferring Pharmaceuticals. FRI is
committed to building a portfolio of novel, innovative peptide-based
drugs and biologicals to address the high unmet medical need for
patients in our therapeutic areas of interest. For more detailed
information please visit www.ferring-research.com
.
About Ferring Pharmaceuticals
Headquartered in Switzerland,
Ferring Pharmaceuticals is a research-driven, specialty
biopharmaceutical group active in global markets. The company
identifies, develops and markets innovative products in the areas of
reproductive health, urology, gastroenterology, endocrinology and
orthopaedics. Ferring has its own operating subsidiaries in nearly 60
countries and markets its products in 110 countries. To learn more about
Ferring or its products please visit www.ferring.com
.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170215005630/en/
Contact:
Ferring Pharmaceuticals
Lindsey Rodger
Tel. +41 58 451 40 23
lindsey.rodger@ferring.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting starter samarbejde med 2i Solutions23.5.2025 12:39:00 CEST | Pressemeddelelse
Andersen Consulting udvider nu sine teknologiske og transformationsmæssige kapaciteter med en samarbejdsaftale med 2i Solutions, der er en virksomhed inden for teknologirådgivning, som bidrager med dybdegående ekspertise inden for ERP og andre specialiserede teknologier for at levere omfattende digitale transformationsløsninger til kunder. 2i Solutions blev grundlagt i 2005 og rådgiver kunder om teknologisk transformation af virksomheder med speciale i implementering, support og tilpasning af SAP. Virksomheden har et stærkt fokus på at levere intelligente forretningsløsninger og tilbyder tjenester inden for SAP S/4HANA-migrering, cloudløsninger, dataanalyse, kunstig intelligens og automatisering af forretningsprocesser. 2i Solutions samarbejder med en bred vifte af kunder inden for forsyning, forsikring, lægemiddelindustrien og fremstillingsbranchen, herunder også den offentlige sektor. Deres branchespecifikke løsninger og globale kapaciteter gør dem i stand til at hjælpe virksomheder,
Reply Announces the Jury for the First AI Music Contest: Finalists Will Perform Live on Stage at Kappa FuturFestival in Turin23.5.2025 10:05:00 CEST | Press release
The jury of the first contest connecting artificial intelligence with the world of live performance comprises the following DJs and artists: Albertino, Nicola Gotti, Jacopo Di Cera, DJ Tennis, Damir Ivic, Ali Demirel, Ale Lippi, Auronda Scalera & Alfredo Cramerotti, Annibale Siconolfi, Seth Troxler. Reply, an international group specialized in the creation of new business models enabled by Artificial Intelligence and driven by a strong culture of innovation, is expanding its creative experimentation initiatives this year with the launch of the AI Music Contest. Organised in collaboration with Kappa FuturFestival, one of Europe’s leading electronic music festivals, the competition is open to creatives and innovators who use AI technologies to explore new forms of integration between sound and visuals. It aims to enhance the expressive potential of artificial intelligence in live performances. This press release features multimedia. View the full release here: https://www.businesswire.co
Kioxia Holdings Corporation Wins IPO of the Year Award in the Equity Category at the DealWatch Awards 202423.5.2025 09:00:00 CEST | Press release
Kioxia Holdings Corporation (TOKYO:285A), a world leader in memory solutions, today announced that it had won the IPO of the Year award in the Equity category at the DealWatch Awards 2024, organized by DealWatch, the most authoritative source of real-time intelligence for deal activity within Japan's capital markets. The award was presented at a ceremony held on May 20. The DealWatch Awards recognize outstanding issuers of bonds or equities in the Japanese capital market, as well as Japanese issuers who have conducted offerings overseas, and the securities firms that manage these transactions. The awards for 2024 comprised six categories: Overall, Bonds, Local Government Bonds, Cross-Border Bonds, Sustainable Finance, and Equity. Selection is based on criteria such as the appropriateness of pricing in the issuance market, price formation after transition to the trading market, contribution to the development of capital markets, and innovative efforts, with the awards designed to promot
Generix Named in the 2025 Gartner® Magic Quadrant™ for Warehouse Management Systems (WMS) for the Seventh Consecutive Year23.5.2025 09:00:00 CEST | Press release
Generix, a global business software company offering an expansive portfolio of SaaS solutions for supply chain, finance, commerce, and B2B integration, today announces it has been recognized by Gartner in the 2025 Gartner® Magic Quadrant™ for Warehouse Management Systems (WMS). This is the seventh consecutive year that Generix has been recognized for its portfolio of WMS Solutions. Designed to scale as supply chain operations grow from simple to complex flows, Generix WMS and Solochain WMS are currently in more than 2,000 warehouses globally. “We are honored to be recognized in the Gartner® Magic Quadrant™ WMS for the seventh consecutive year. Generix continues its commitment to providing WMS for every warehousing need at a global scale. With our two recognized WMS solutions, Generix WMS and Solochain WMS, we continue to innovate to better serve customer needs with the introduction of industry game-changing AI use-cases such as resource planning and computer vision,” said Si-Mohamed Sa
NuORDER by Lightspeed and Mandatory Renew Partnership to Power Hybrid Commerce at the Third Edition of the Copenhagen Event23.5.2025 09:00:00 CEST | Press release
Third edition of the trade event will merge physical and digital experiences, supporting the vibrant and fast-growing Nordic fashion community Mandatory and NuORDER by Lightspeed, the industry’s leading B2B commerce platform, are joining forces for the third consecutive time to power the digital extension of Mandatory’s in-person trade event, taking place August 5–7 in Copenhagen. This renewed partnership reflects the continued momentum behind hybrid commerce—where physical and digital trade intersect to create smarter, more flexible buying experiences. As the Nordic fashion ecosystem expands with energy and innovation, Mandatory has become a magnet for trendsetting brands and forward-looking retailers. On NuORDER’s wholesale platform, buyer activity from Nordic-region retailers surged by 39.4% year over year in Q1 2025 (January to March). "Retailers in the Nordic region have been quick to adopt digital tools to enhance the efficiency of their buying processes. The increase in buyer ac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom